Balancing Quality, Consistency & Scalability of Starting Cell Lines through Strategic Selection
Time: 9:10 am
day: Pre-Conference Workshop Day
Details:
Choosing the right iPSC starting line is fundamental to influencing safety, efficacy, and manufacturability. Key factors such as donor selection, genomic stability, and differentiation potential must be carefully evaluated alongside evolving regulatory expectations. This session will explore best practices for optimizing cell line selection, balancing standardization with therapy-specific requirements.
